NCT00616278已完成不适用
National Cooperative Growth Study of Nutropin AQ, Nutropin, Protropin, and Nutropin Depot in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End-Stage Renal Disease (ESRD)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 27
- 试验地点
- 1
- 主要终点
- The primary outcome measures of the NCGS are ongoing safety and efficacy of Genentech GH preparations in pediatric growth disorders for which GH is initiated.
研究概览
简要总结
The purpose of this study is to learn whether growth hormone being administered to children with Chronic Kidney Disease is effective and if it has any side effects.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 1 Day 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Must be a patient of the UC Davis Medical Center pediatric clinic with Chronic Kidney Disease
排除标准
- •Greater than 18 years old
- •Not a patient at the UC Davis Medical Center pediatric clinic
结局指标
主要结局
The primary outcome measures of the NCGS are ongoing safety and efficacy of Genentech GH preparations in pediatric growth disorders for which GH is initiated.
时间窗: per the study, the pt will be on GH treatement until the physician instructs them to stop
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Effect of Growth Hormone in Children With Growth Hormone DeficiencyGrowth Hormone DisorderGrowth DisorderIdiopathic Short StatureGrowth Hormone Deficiency in ChildrenNCT00262249Novo Nordisk A/S173
已完成
4 期
Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?Prader-Willi SyndromeGrowth Hormone DeficiencyNCT01298180University Hospital, Toulouse111
进行中（未招募）
不适用
A study to determine the effects of growth hormone (GH) replacement therapy on quality of life and cardiovascualr risk in GH deficient adults - Growth Hormone and Quality of Life (GroH-QoL)EUCTR2004-004835-72-GBniversity of Birmingham200
已完成
3 期
Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone DeficiencyGrowth Hormone DeficiencyNCT01060488Merck KGaA, Darmstadt, Germany69
已完成
3 期
Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational AgeGrowth DisordersNCT00174408Pfizer110